Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil Compared to Linezolid Administered Intravenously and Orally to Adult Subjects With Acute Bacterial Skin and Skin Structure Infection
NCT03747497 is registered in ClinicalTrials.gov with MicuRx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil Compared to Linezolid Administered Intravenously and Orally to Adult Subjects With Acute Bacterial Skin and Skin Structure Infection
- Lead sponsor
- MicuRx
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 15, 2018
- Completion date
- March 26, 2019
- Enrollment
- 196 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.